Last reviewed · How we verify
NCT04118218: Rhizolyse
Determination of Predictive Clinical Signs of Effective Rhizolysis Using the DFL Questionnaire.
NA trial testing Rhizolysis pain analysis in Rhizolysis in 100 participants. Status unknown.
31 March 2020
Quick facts
| Lead sponsor | Ramsay Générale de Santé |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 12 December 2017 |
| Primary completion | 31 March 2020 |
| Estimated completion | 31 March 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Rhizolysis pain analysis
Conditions studied
- Rhizolysis — all drugs for Rhizolysis →
- Diagnosis of Facet Joint Origin Lumbago — all drugs for Diagnosis of Facet Joint Origin Lumbago →
Sponsor
Ramsay Générale de Santé — full company profile →
Who can join
18 and older, any sex, with Rhizolysis or Diagnosis of Facet Joint Origin Lumbago. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rhizolysis or lumbar thermocoagulation is a therapeutic proposal for certain types of chronic lower back pain that is resistant to medical treatment and outside the field of surgical indications. A previous study has selected functional and physical signs selected by analysts and a group of experts from the modified "Delphi" prediction method. This study resulted in the creation of a questionnaire (DFL questionnaire) with 16 symptoms: 7 functional and 9 physical. The aim of this new study is to select the symptoms that have the best positive predictive value among the 16 symptoms, to predict a good result of rhizolysis, on the criterion of their mitigation or disappearance in case of effective rhizolysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04118218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ramsay Générale de Santé trials
Trials by the same sponsor.
- NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
- NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
- NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
- NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
- NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04118218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
- Last refreshed: 8 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04118218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing